Chapter

Supportive Care in Cancer Patients

Volume 108 of the series Recent Results in Cancer Research pp 89-101

Controlling Emesis in Patients Receiving Cancer Chemotherapy

  • R. J. GrallaAffiliated withSolid Tumor Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center
  • , M. G. KrisAffiliated withSolid Tumor Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center
  • , L. B. TysonAffiliated withSolid Tumor Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center
  • , R. A. ClarkAffiliated withSolid Tumor Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Over the past several years, the appropriate use of antiemetics has increased, as has the ability to control chemotherapy-associated nausea and vomiting. With greater use of chemotherapy and with the development of newer agents in which emesis is a major side-effect, the need for improved control of nausea and vomiting has become an important consideration in medical oncology and in supportive care. The primary objective of this paper is to provide a practical guide that discusses some of the major issues in the antiemetic approach to the patient receiving chemotherapy.